TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma have?
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma has 110 citations in the OpenAlex counts ScholarIQ stores.
When was TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma published?
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma has 2018 year in the ScholarIQ index.
What is the open-access status of TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma?
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma has gold oa status in the ScholarIQ index.
What is the DOI of TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma?
The DOI for TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma is on the source record.
What is the PMID of TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma?
The PMID for TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma is on the source record.
What is the OpenAlex record for TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma?
The OpenAlex for TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma is on the source record.